Is Lexaria Bioscience Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Lexaria Bioscience Corp (LEXX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Lexaria Bioscience Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lexaria Bioscience Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Lexaria Bioscience Corp?

Muslim investors may consider investing in Lexaria Bioscience Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Lexaria Bioscience Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Lexaria Bioscience Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Lexaria Bioscience Corp updated?

The Shariah compliance status of Lexaria Bioscience Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Lexaria Bioscience Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Lexaria Bioscience Corp?

You can check the latest Shariah compliance status of Lexaria Bioscience Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

LEXX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 30, 2026

Report Source: 2026 2nd Quarter Report

Lexaria Bioscience Corp. Stock Analysis LEXX

United States Health Care Nano Cap Report: Q2, 2026

Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. The company is headquartered in Kelowna, British Columbia and currently employs 7 full-time employees. The company went IPO on 2009-10-28. The firm's patented drug delivery formulation and processing platform technology improves the way a wide variety of drugs enter the bloodstream, always through oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. The Company’s segment includes Intellectual Property, B2B Production, and Research and Development. The company is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its focus is the investigation and the incorporation of its DehydraTECH drug delivery technology with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) to enhance absorption and reduce adverse side effects. The firm operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 48 patents granted and many patents pending worldwide.

Key Statistics of Lexaria Bioscience Corp (LEXX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.58$0.62

Today's Open

$0.62

Volume

43.79K

P/E Ratio (TTM)

52 Week Range

$0.46$1.55

Market Cap

17.18M

Avg. Volume

194.19K

Dividend Yield

Financial Metrics & Statements of Lexaria Bioscience Corp (LEXX)

FAQ's for Lexaria Bioscience Corp (LEXX)

According to Musaffa’s Shariah screening methodology, Lexaria Bioscience Corp (LEXX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.